Results on compliance with principles for responsible clinical trial data sharing published

Article summary

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published its conclusions on the July–September 2022 survey among member companies on their compliance with the EFPIA-Pharmaceutical Research and Manufacturers of America (PhRMA) principles for responsible clinical trial data sharing, published in 2014. The survey found that the compliance rate with the EFPIA-PhRMA principles was ‘generally very high’, but some aspects did not reach 100%. It also found that the challenges with implementing the principles lay in specific process demands related to data sharing, and that many companies go beyond the reporting and data sharing requirements, such as providing ‘Lay Language Summaries’ for trial participants and the public.